[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Risk](https://github.com/mm80843/T3.5/tree/pages/docs/Risk/index.md) >> Individual ID:PBN__Risk_10795 

# __Increased thrombotic and micro-vascular complications in severe covid-19 patients, leading to covid-19-associated coagulopathy cac__

## Articles mentionning the risk

* [Wu_current_2021](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_509.md)

## Mitigations of this risk

* [Implement anticoagulant therapy and closely monitor patients for signs of coagulopathy](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_12706.md)

## Name of the risk

Higher risk of mortality and severity of COVID-19

## People affected by this risk

* [Particularly those in icu](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_8750.md)
* [Severe covid-19 patients](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_8751.md)

## Stakeholders who can mitigate this risk

* [Healthcare professionals](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_32.md)
* [Medical staff](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_93.md)

## Technologies linked to the risk

* [Advanced monitoring systems](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_1127.md)
* [Anticoagulant medications](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_12707.md)

## This Risk belongs to this RiskGroup

* [Public health risks](https://github.com/mm80843/T3.5/blob/pages/RiskGroup/PBN__RiskGroup_3.md)

